Should I weight-adjust my NMN dose?

In published trials, dosing has been roughly proportional to body weight, but commercial supplement labels typically use fixed doses (250mg, 500mg) rather than mg-per-kg formulas. The Igarashi 2022 trial used 250mg/day in older Japanese men averaging around 65kg, putting them near 4mg/kg/day. Yoshino 2021 used 250mg in postmenopausal women averaging 70kg, similar mg/kg. Liao 2021 used 300mg in middle-aged runners. As a rough guide, 4-7mg/kg/day brackets the studied range. For a 50kg petite Malaysian woman, 250mg/day sits at 5mg/kg - comfortably within the trial range. For a 95kg Malaysian man, 500mg/day is closer to 5mg/kg and may be more appropriate than 250mg. The honest caveat: NMN's pharmacokinetics show dose-response saturation at higher levels, so doubling the dose does not double the NAD+ rise. The 250mg-vs-500mg difference is real but not proportional. Practical protocol: start everyone at 250mg/day for 2 weeks regardless of weight to assess tolerance. Then escalate to 500mg if you are over 75kg, on heavy training load, or noting no subjective response at 250mg. Stay at 250mg if you are under 60kg, sensitive to supplements generally, or older than 65. There is no clear evidence that dosing above 500-600mg/day adds meaningful benefit for most users - the highest published doses (1,250mg in some trials) showed no obvious additional benefit over 500mg.

Why this matters for Malaysian buyers

NMN buying decisions in Malaysia involve a stack of considerations that don't always map to advice from US- or EU-focused sources: NPRA notification status, JAKIM halal certification (or its absence), tropical-climate storage realities, mall pharmacy versus Shopee Malaysia tradeoffs, and how local medical practitioners typically respond to questions about supplements outside their training. We answer questions like "Should I weight-adjust my NMN dose?" through the lens of Malaysian buyer realities - not generic global guidance.

Verify the source

This individual Q&A is a supporting note, not an indexable authority article. Health-relevant claims should be refreshed against the linked primary or official sources before they are used for buying or medical discussions.

• Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects (2022)
• Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women (2021)
• Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men (2022)
• The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial (2023)
• Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study (2021)
• World Anti-Doping Agency Prohibited List (2026)

Adjacent tools

Need to act on this answer? Try the halal checker, the cost calculator, the stack builder, or the brand selector quiz - each tool turns advice into actionable output for your specific situation.

More questions? Browse the full Q&A library (10 categories) · See our main FAQ · Browse NMN brand comparisons · NR brand comparisons.